Accession Number: | 0001415889-21-002957 |
Date: | 2021-06-10 |
Issuer: | OLEMA PHARMACEUTICALS, INC. (OLMA) |
Original Submission Date: |
HORN KINNEY
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO, CA 94107
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-10 | M | 5,251 | a | $2.06 | 7,041 | direct | ||
COMMON STOCK | 2021-06-10 | S | 300 | d | $28.30 | 6,741 | direct | ||
COMMON STOCK | 2021-06-10 | S | 2,164 | d | $29.60 | 4,577 | direct | ||
COMMON STOCK | 2021-06-10 | S | 2,787 | d | $29.97 | 1,790 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.064 | 2021-06-10 | deemed execution date | M | 5,251 (d) | 2030-06-09 | common stock 5,251 | $2.06 | 189,046 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. |
f2 | the weighted average sale price for the transaction reported was $28.30, and the range of prices were between $27.79 and $28.63. upon request from the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
f3 | the weighted average sale price for the transaction reported was $29.60, and the range of prices were between $28.81 and $29.80. upon request from the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
f4 | the weighted average sale price for the transaction reported was $29.97, and the range of prices were between $29.82 and $30.21. upon request from the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
f5 | the shares subject to the option vest in a series of 48 successive equal monthly installments measured from june 10, 2020, subject to the reporting person's continuous service through each applicable vesting date. |